Baxter International announced it will form a R&D center in Cambridge, Massachusetts for its new biopharmaceutical company, Baxalta.
Ashley Roberts
Advertisement
Articles by Ashley Roberts
AMAG Pharmaceuticals announced the acquisition of women?s health brand, Lumara Health, for $675 million, with an additional contingency of up to $350 million.
Johnson & Johnson announced the acquisition of Alios BioPharma to expand their portfolio of therapeutics for viral infections.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
